Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment
- PMID: 3249924
- DOI: 10.3109/00365528809090202
Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment
Abstract
We have studied the relationship between reduction of gastric acid secretion and fasting plasma gastrin concentrations during once daily omeprazole treatment. Healthy subjects were given omeprazole for 5 days in daily doses of 5, 10, 20, 40, or 80 mg. Acid secretion and fasting gastrin concentration were measured 6 h (maximal omeprazole effect) and 24 h (minimal omeprazole effect) after the fifth omeprazole dose. Omeprazole in doses lower than 20 mg daily did not suppress pentagastrin-stimulated acid secretion in all subjects 6 h after dosing on the 5th day. Doses of 20-80 mg omeprazole, however, significantly reduced acid secretion 24 h after the fifth dose, the range being 36-76%. A relationship between degree of acid inhibition and fasting gastrin concentration was observed. However, acid secretion needed to be reduced by more than 80% before gastrin levels were clearly affected. This degree of acid inhibition was only achieved 6 h after administration of omeprazole in doses of 20 mg and higher. The inhibitory effect of omeprazole on acid secretion decreased 24 h after dosing. Thus, fasting gastrin concentrations were moderately increased in the beginning and normalized at the end of each 24-h period during treatment with daily doses of 20-80 mg omeprazole.
Similar articles
-
Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.Eur J Clin Pharmacol. 1991;40(6):557-60. doi: 10.1007/BF00279969. Eur J Clin Pharmacol. 1991. PMID: 1884735
-
Effect of omeprazole on gastric acid secretion and plasma gastrin in man.Scand J Gastroenterol Suppl. 1989;166:27-32; discussion 41-2. doi: 10.3109/00365528909091240. Scand J Gastroenterol Suppl. 1989. PMID: 2690329 Review.
-
Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.Eur J Clin Pharmacol. 1989;37(4):345-9. doi: 10.1007/BF00558498. Eur J Clin Pharmacol. 1989. PMID: 2598968
-
Effect of omeprazole on gastric acid secretion and plasma gastrin.J Gastroenterol Hepatol. 1989;4 Suppl 2:19-25. J Gastroenterol Hepatol. 1989. PMID: 2491358 Review.
-
Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.Dig Dis Sci. 1986 Jun;31(6):561-6. doi: 10.1007/BF01318685. Dig Dis Sci. 1986. PMID: 3086061 Clinical Trial.
Cited by
-
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.Dig Dis Sci. 1994 Jul;39(7):1473-82. doi: 10.1007/BF02088051. Dig Dis Sci. 1994. PMID: 8026259 Clinical Trial.
-
Omeprazole: gastrin and gastric data (August 1991).Dig Dis Sci. 1991 Oct;36(10):1501-2. doi: 10.1007/BF01296825. Dig Dis Sci. 1991. PMID: 1914779 No abstract available.
-
Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.Drug Saf. 1994 Jan;10(1):66-82. doi: 10.2165/00002018-199410010-00005. Drug Saf. 1994. PMID: 8136088 Review.
-
Omeprazole causes delay in gastric emptying of digestible meals.Dig Dis Sci. 1996 Mar;41(3):469-74. doi: 10.1007/BF02282320. Dig Dis Sci. 1996. PMID: 8617117
-
Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors?Dig Dis Sci. 2000 Jan;45(1):34-9. doi: 10.1023/a:1005496907686. Dig Dis Sci. 2000. PMID: 10695611
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources